Chen S, Ou R, Wei Q, Zhao B, Chen X
Ther Adv Neurol Disord. 2025; 18:17562864251314746.
PMID: 40012687
PMC: 11863258.
DOI: 10.1177/17562864251314746.
Alberti C, Molitierno N, Iacobelli V, Velardo D, Comi G, Corti S
Ther Adv Neurol Disord. 2024; 17:17562864241297086.
PMID: 39628849
PMC: 11613286.
DOI: 10.1177/17562864241297086.
Thatikonda N, Lerint A, Valaparla V, Patel C
J Med Cases. 2024; 15(11):341-346.
PMID: 39421225
PMC: 11483148.
DOI: 10.14740/jmc4305.
Wang L, Song G, Su H
J Int Med Res. 2024; 52(9):3000605241274570.
PMID: 39225009
PMC: 11375649.
DOI: 10.1177/03000605241274570.
Diggikar P, Pancholi T, Yammanuru B, Mundada M, R J
Cureus. 2024; 16(7):e65561.
PMID: 39192912
PMC: 11349248.
DOI: 10.7759/cureus.65561.
The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis.
Noioso C, Bevilacqua L, Acerra G, Valle P, Serio M, Pecoraro A
Neurol Sci. 2024; 45(12):5657-5669.
PMID: 38987510
DOI: 10.1007/s10072-024-07686-3.
A case report of thrombocytopenic COVID-19 and Miller-Fisher syndrome on a concurrent chronic immune neuropathy.
Blackbourn L, Hamid U, Tokala J, Blume G
Medicine (Baltimore). 2024; 103(21):e38304.
PMID: 38788032
PMC: 11124588.
DOI: 10.1097/MD.0000000000038304.
Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndrome.
Coly M, Adams D, Attarian S, Bouhour F, Camdessanche J, Carey G
J Neurol. 2024; 271(8):4982-4990.
PMID: 38767661
DOI: 10.1007/s00415-024-12410-4.
Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions.
Hughes R
Eur J Neurol. 2024; 31(11):e16346.
PMID: 38752584
PMC: 11464409.
DOI: 10.1111/ene.16346.
The Clue is in the Eyes. A Case Report of Internuclear Ophthalmoplegia.
Nickels C, Keyes C, Astemborski C, Fulton H
J Educ Teach Emerg Med. 2024; 9(1):V1-V8.
PMID: 38344047
PMC: 10854879.
DOI: 10.21980/J8DP9M.
Letter to the editor: Blurry vision as the initial symptom in Guillain-Barré syndrome: a case report.
Song J, Song Y, Wang Y, Zhang G
Neurol Sci. 2024; 45(5):2393-2394.
PMID: 38206432
DOI: 10.1007/s10072-024-07306-0.
Non-reactive pupils as early sign of Miller Fisher syndrome.
Curr J Neurol. 2023; 19(3):152-153.
PMID: 38011405
PMC: 8185588.
DOI: 10.18502/cjn.v19i3.5430.
Miller-Fisher Syndrome With Initial Manifestation of Rhinolalia Aperta: A Case Report and Literature Review.
Pacut P, Han J, Ghasemi M
Cureus. 2023; 15(10):e46376.
PMID: 37927683
PMC: 10620625.
DOI: 10.7759/cureus.46376.
Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies.
Alijanzadeh D, Soltani A, Afra F, Salmanpour F, Loghman A, Samieefar N
BMC Neurol. 2023; 23(1):332.
PMID: 37735648
PMC: 10512542.
DOI: 10.1186/s12883-023-03375-4.
Miller Fisher syndrome: an updated narrative review.
Noioso C, Bevilacqua L, Acerra G, Valle P, Serio M, Vinciguerra C
Front Neurol. 2023; 14:1250774.
PMID: 37693761
PMC: 10484709.
DOI: 10.3389/fneur.2023.1250774.
Miller Fisher Syndrome Associated With COVID-19: A History of Molecular Mimicry and an Up-to-Date Review of the Literature.
Poyraz T
Cureus. 2023; 15(8):e43111.
PMID: 37692684
PMC: 10484161.
DOI: 10.7759/cureus.43111.
Clinical Features and Differences of Miller Fisher Syndrome in Southern China: Retrospective Analysis of 72 Patients in 13 Provinces of Southern China.
Yu H, Ding M, Cao Q, Zhou R, Yao J, Fu R
J Clin Neurol. 2023; 19(6):589-596.
PMID: 37455512
PMC: 10622728.
DOI: 10.3988/jcn.2022.0370.
Immune-Mediated Neuropathies: Pathophysiology and Management.
Shastri A, Al Aiyan A, Kishore U, Farrugia M
Int J Mol Sci. 2023; 24(8).
PMID: 37108447
PMC: 10139406.
DOI: 10.3390/ijms24087288.
A Rare Case of Miller Fisher Syndrome in a 45-Year-Old Female.
Duvuru R, Raju S, Nawaz F
Cureus. 2023; 15(3):e36387.
PMID: 37090296
PMC: 10113916.
DOI: 10.7759/cureus.36387.
Miller Fisher Syndrome Associated With COVID-19: A Child Case Report and an Up-to-Date Review of the Literature.
Poyraz T
Cureus. 2023; 15(3):e35656.
PMID: 37009389
PMC: 10065806.
DOI: 10.7759/cureus.35656.
